Atlas Trials

Apatinib Combined With S-1 as Maintenance Therapy for HER-2 Negatived Gastric Cancer

Clinical trial NCT03950141 · UNKNOWN

Trial details

NCT number
NCT03950141
Sponsor
Beijing Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
HER-2 Negatived Gastric Cancer
Start date
2017-07-01
Primary completion
2019-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.